跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANDID-V3 VAGINAL TABLET 200 MG - HSA Drug Approval Details
Approvals
/
HSA
/
CANDID-V3 VAGINAL TABLET 200 MG
Approved
THERAPEUTIC
CANDID-V3 VAGINAL TABLET 200 MG
GLENMARK PHARMACEUTICALS LTD (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 16, 1989
Approval ID
3c57842bddd14c81
Company
GLENMARK PHARMACEUTICALS LTD (INDIA)
Type
Therapeutic
Approval Details
Approval Id
3c57842bddd14c81
Drug Name
CANDID-V3 VAGINAL TABLET 200 MG
Product Name
CANDID-V3 VAGINAL TABLET 200 MG
Approval Number
SIN03396P
Approval Date
1989-06-16
Registrant
UNI DRUG HOUSE
Licence Holder
UNI DRUG HOUSE
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
VAGINAL
Atc Code
G01AF02
Atc Item Name
clotrimazole
Pharma Manufacturer Name
UNI DRUG HOUSE SDN. BHD.
Company Detail Path
/organization/uni-drug-house-sdn-bhd
Active Ingredients
CLOTRIMAZOLE
200 mg
CLOTRIMAZOLE
200 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 16, 1989
Approval ID
3c57842bddd14c81
Type
Therapeutic
Back to HSA Approvals